Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Gamida Cell Ltd

GMDA
Current price
0.32 USD -0.014 USD (-4.13%)
Last closed 0.32 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 43 770 872 USD
Yield for 12 month -75.00 %
Week
Month
Year
GMDA
21.11.2021 - 28.11.2021

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel. Address: 5 Nahum Heftsadie Street, Jerusalem, Israel, 91340

Analytics

WallStreet Target Price

4 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+673 000 USD

Last Quarter

Current Year

Last Year

Current Quarter

+47 000 USD

Last Quarter

Key Figures GMDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -75 910 000 USD
Operating Margin TTM -2680.24 %
PE Ratio
Return On Assets TTM -41.47 %
PEG Ratio
Return On Equity TTM -1103.79 %
Wall Street Target Price 4 USD
Revenue TTM 673 000 USD
Book Value 0.003 USD
Revenue Per Share TTM 0.007 USD
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -0.82 USD
Diluted Eps TTM -0.82 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics GMDA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GMDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GMDA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 101.9082
Price Sales TTM 65.0384
Enterprise Value EBITDA -0.9035
Price Book MRQ 114.6525

Financials GMDA

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GMDA

For 52 weeks

0.22 USD 2.51 USD
50 Day MA 0.71 USD
Shares Short Prior Month 7 346 575
200 Day MA 1.3 USD
Short Ratio 5.51
Shares Short 8 256 781
Short Percent 6.54 %